The effects of intravesical therapy with hyaluronic acid for painful bladder syndrome: Preliminary Chinese experience and systematic review

Taiwan J Obstet Gynecol. 2015 Jun;54(3):240-7. doi: 10.1016/j.tjog.2014.09.007.

Abstract

Objective: To present the preliminary results of treating a series of Chinese patients with painful bladder syndrome/interstitial cystitis (PBS/IC) using intravesical hyaluronic acid (HA).

Materials and methods: A series of 13 patients with PBS/IC received first-line therapy followed by HA once-a-week for 4 weeks and then once monthly for 4 months. Outcomes measured included O'Leary-Sant Interstitial Cystitis Symptom Index (ICSI) and Interstitial Cystitis Problem Index (ISPI) scores, voiding frequency, and bladder capacity.

Results: ISPI and ICSI scores were significantly (p < 0.001) decreased after treatment [median change (interquartile range): ISPI = 2 (2-3); ICSI = 3 (2-3)]. Voiding frequency and functional bladder capacity were significantly (p < 0.001) decreased [median change: 7 (6-8) times/d] and increased [median change: 190 (116-233) mL], respectively after treatment.

Conclusion: Our case series supports the efficacy of intravesical HA in the treatment of PBS/IC.

Keywords: hyaluronic acid; interstitial cystitis; intravesical therapy; painful bladder syndrome.

Publication types

  • Review
  • Systematic Review

MeSH terms

  • Adjuvants, Immunologic / administration & dosage*
  • Administration, Intravesical
  • Adult
  • China
  • Cystitis, Interstitial / drug therapy*
  • Cystitis, Interstitial / pathology
  • Cystitis, Interstitial / physiopathology
  • Female
  • Humans
  • Hyaluronic Acid / administration & dosage*
  • Male
  • Severity of Illness Index
  • Young Adult

Substances

  • Adjuvants, Immunologic
  • Hyaluronic Acid